- Companies
- Hargreave Hale AIM VCT
Hargreave Hale AIM VCT Valuation Multiples
Hargreave Hale AIM VCT is valued at $156M as of November 2026, a 174.7x revenue multiple. In the last fiscal year, Hargreave Hale AIM VCT revenue was $821K.
Hargreave Hale AIM VCT Overview
About Hargreave Hale AIM VCT
Hargreave Hale AIM VCT is a venture capital trust whose shares are listed on the main market of the London Stock Exchange and which invests in small, high-growth UK companies, mostly companies traded on AIM, as well as unquoted businesses. Launched in 2004, it holds a diversified portfolio across a wide range of sectors, and many of its most successful investments have been held for more than ten years. As an HMRC-approved investment company, it offers investors upfront income tax relief on new shares held for at least five years, tax-free dividends and exemption from capital gains tax, in return for investing in VCT-qualifying companies, which must have a permanent UK establishment, fewer than 250 employees and gross assets below £15 million. The trust has an independent board of non-executive directors, publishes regular net asset value updates and pays regular tax-free dividends to shareholders. Its website and marketing communications are operated by Canaccord Genuity Wealth Limited, and it raises new capital from investors through periodic offers for subscription.
Founded
2004
HQ
Employees
0
Website
Sectors
Financials (Last FY)
EV
$144M
Valuation Multiples
Start free trialHargreave Hale AIM VCT Financials
Hargreave Hale AIM VCT reported last fiscal year revenue of $821K.
In the same fiscal year, Hargreave Hale AIM VCT generated had net loss of ($700K).
Hargreave Hale AIM VCT P&L
In the most recent fiscal year, Hargreave Hale AIM VCT reported revenue of $821K and net income of ($700K).
Hargreave Hale AIM VCT is unprofitable as of last fiscal year, with net margin of (85%).
Financial data powered by Morningstar, Inc.
Hargreave Hale AIM VCT Stock Performance
Hargreave Hale AIM VCT has current market cap of $156M, and enterprise value of $144M.
Market Cap Evolution
Hargreave Hale AIM VCT's stock price is $0.42.
Hargreave Hale AIM VCT share price increased by 3.9% in the last 30 days.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $144M | $156M | -0.2% | 3.9% | - | - | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHargreave Hale AIM VCT Valuation Multiples
Hargreave Hale AIM VCT trades at 174.7x EV/Revenue multiple.
Hargreave Hale AIM VCT Financial Valuation Multiples
As of November 8, 2026, Hargreave Hale AIM VCT has market cap of $156M and EV of $144M.
Hargreave Hale AIM VCT has a P/E ratio of (222.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hargreave Hale AIM VCT Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hargreave Hale AIM VCT Margins & Growth Rates
In the most recent fiscal year, Hargreave Hale AIM VCT reported net margin of (85%).
Hargreave Hale AIM VCT Margins
Hargreave Hale AIM VCT Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hargreave Hale AIM VCT Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Hargreave Hale AIM VCT Competitors
Hargreave Hale AIM VCT competitors include Graf Global, Triple Point Venture VCT, Stack Capital Group, SuRo Capital, DAOL Investment, Spectral Capital, GalaxyEdge Acquisition, APEX Tech Acquisition, Mercia Asset Management and Morgan Stanley Emerg Mkts.
Most Hargreave Hale AIM VCT public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($2M) | - | - | (85.1x) | - | |||
| $4M | - | 28.3x | - | - | - | |||
| $11M | $9M | 13.0x | 2.1x | 15.7x | - | |||
| $67M | - | 2.9x | 121.7x | - | - | |||
| $256M | - | 0.6x | - | - | - | |||
| $22M | $2M | 7.5x | - | 79.9x | - | |||
| - | ($45K) | - | - | (3576.4x) | - | |||
| - | - | - | - | - | - | |||
This data is available for Pro users. Sign up to see all Hargreave Hale AIM VCT competitors and their valuation data. Start Free Trial | ||||||||
Investments by Hargreave Hale AIM VCT
Hargreave Hale AIM VCT has invested in 4 companies to date.
Latest investment by Hargreave Hale AIM VCT was on September 29th 2026. Hargreave Hale AIM VCT invested in 52 North Health in their $4M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Hargreave Hale AIM VCT
| Description | 52 North Health is a UK-based medical technology firm developing AI-powered devices for chemotherapy patients. Its wearable sensor detects early signs of neutropenic sepsis by monitoring vital signs and biomarkers. The product integrates with hospital systems for real-time alerts. Founded in 2020 and headquartered in Belfast, 52 North Health has conducted trials with NHS trusts and secured CE marking. It aims to reduce sepsis mortality rates through predictive analytics. | Qureight is an imaging analytics company applying AI to thoracic diseases like idiopathic pulmonary fibrosis and lung cancer. Its LungQ platform quantifies CT scans for fibrosis extent, cancer nodules, and emphysema severity, aiding clinical trials and diagnostics. London-based Qureight collaborates with AstraZeneca and Boehringer Ingelheim. | Qureight is an imaging analytics company applying AI to thoracic diseases like idiopathic pulmonary fibrosis and lung cancer. Its LungQ platform quantifies CT scans for fibrosis extent, cancer nodules, and emphysema severity, aiding clinical trials and diagnostics. London-based Qureight collaborates with AstraZeneca and Boehringer Ingelheim. | AirPortr is a London-headquartered baggage technology provider operating at 20 airports including Heathrow and JFK since 2016. Its app-based system allows early bag drop at hotels or city centers, reducing terminal queues and landside operations for airlines like British Airways. The service handles 1 million bags yearly, integrating with airline check-in for seamless tracking. | |
| HQ Country | |||||
| HQ City | - | Cambridge | Cambridge | London | |
| Deal Date | 29 Sep 2026 | 28 Jul 2026 | 16 Apr 2024 | 16 Aug 2019 | |
| Round | Undisclosed stage | Series B | Series A | Series A | |
| Raised | $4M | $20M | $9M | $9M | |
| Investors | Cancer Research Horizons; OKG Capital; Macmillan Cancer Support; Cedars Sinai; University of Cambridge Enterprise; Hargreave Hale AIM VCT | Guinness Ventures; Meltwind Advisory; Molten Ventures; XTX Ventures; Hargreave Hale AIM VCT; Ascension | Guinness Ventures; Ascension Life Fund; Meltwind Advisory; Playfair Capital; XTX Ventures; Hargreave Hale AIM VCT; Cambridge Angels group; Nexenai Capital | Force Over Mass Capital; Esken; Hargreave Hale AIM VCT; JamJar Investments; Vela Technologies | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Hargreave Hale AIM VCT investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hargreave Hale AIM VCT
| When was Hargreave Hale AIM VCT founded? | Hargreave Hale AIM VCT was founded in 2004. |
| Where is Hargreave Hale AIM VCT headquartered? | Hargreave Hale AIM VCT is headquartered in United Kingdom. |
| How many employees does Hargreave Hale AIM VCT have? | As of today, Hargreave Hale AIM VCT has over 0 employees. |
| Is Hargreave Hale AIM VCT publicly listed? | Yes, Hargreave Hale AIM VCT is a public company listed on London Stock Exchange. |
| What is the stock symbol of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT trades under HHV ticker. |
| Who are competitors of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT main competitors include Graf Global, Triple Point Venture VCT, Stack Capital Group, SuRo Capital, DAOL Investment, Spectral Capital, GalaxyEdge Acquisition, APEX Tech Acquisition, Mercia Asset Management, Morgan Stanley Emerg Mkts. |
| What is the current market cap of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT's current market cap is $156M. |
| What is the current revenue of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT's last fiscal year revenue is $821K. |
| What is the current EV/Revenue multiple of Hargreave Hale AIM VCT? | Current revenue multiple of Hargreave Hale AIM VCT is 174.7x. |
| Is Hargreave Hale AIM VCT profitable? | No, Hargreave Hale AIM VCT is not profitable. |
| How many companies Hargreave Hale AIM VCT has acquired to date? | Hargreave Hale AIM VCT hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hargreave Hale AIM VCT has invested to date? | As of November 2026, Hargreave Hale AIM VCT has invested in 4 companies. |
| What was the last Hargreave Hale AIM VCT investment? | On 29th September 2026 Hargreave Hale AIM VCT invested in 52 North Health, participating in a $4M Undisclosed stage round, alongside Cancer Research Horizons, OKG Capital, Macmillan Cancer Support, Cedars Sinai, and University of Cambridge Enterprise. |
| In what companies Hargreave Hale AIM VCT invested in? | Hargreave Hale AIM VCT invested in Qureight, AirPortr, 52 North Health, and HonestBrew. |
See public comps similar to Hargreave Hale AIM VCT
Lists including Hargreave Hale AIM VCT
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




